Behind the Science: How Blood Tests Could Transform Ovarian Cancer Detection
Failed to add items
Sorry, we are unable to add the item because your shopping cart is already at capacity.
Add to Cart failed.
Please try again later
Add to Wish List failed.
Please try again later
Remove from wishlist failed.
Please try again later
Adding to library failed
Please try again
Follow podcast failed
Please try again
Unfollow podcast failed
Please try again
-
Narrated by:
-
By:
A simple blood test may one day detect ovarian cancer before it’s visible on a scan. This episode of Teal Talk–An Ovarian Cancer Podcast explores how liquid biopsy—a test that finds fragments of tumor DNA in the bloodstream—could change the future of diagnosis and treatment.
Listen as Dr. Hardesty, a member of NOCC’s Medical & Scientific Advisory Board, explains what makes liquid biopsy different from CA-125 or genetic testing, and why researchers are hopeful about its role in early detection.
📋 Take our quick listener survey: https://bit.ly/tealtalksurvey 👉 Learn more about NOCC’s mission: https://ovarian.org Disclaimer: For informational purposes only; not a substitute for medical advice.
No reviews yet